PureTech Health (LON:PRTC) Trading Up 14.6% - Here's What Happened

PureTech Health plc (LON:PRTC - Get Free Report) was up 14.6% during mid-day trading on Saturday . The stock traded as high as GBX 118 ($1.57) and last traded at GBX 118 ($1.57). Approximately 1,623,564 shares changed hands during mid-day trading, an increase of 54% from the average daily volume of 1,056,594 shares. The stock had previously closed at GBX 103 ($1.37).

PureTech Health Stock Up 0.8 %

The firm has a market cap of £370.67 million, a PE ratio of -5.06 and a beta of 1.02. The business's 50 day moving average price is GBX 133.46 and its 200 day moving average price is GBX 147.37. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.